Skip to content

5 Stocks That Should Benefit From The 2026 Medicare Advantage Rate Decision

The Centers for Medicare & Medicaid Services (CMS) finalized the 2027 Medicare Advantage payment rate at a +2.48% net average increase, well above the +0.09% proposed in January and above the roughly 1% street expectation.

The decision injects over $13 billion into private insurers serving 35 million Medicare Advantage beneficiaries, triggering a broad relief rally across managed care stocks punished all year on fears of a near-flat rate environment.

Medicare Advantage is the private-insurer alternative to traditional Medicare. Insurers bid to cover seniors, and CMS sets benchmark payment rates annually. When rates rise meaningfully, insurers collect more per member, improving margins and enabling benefit enhancements that attract enrollment. When rates disappoint, benefit ratios deteriorate and earnings guidance gets cut.

These five stocks are the primary vehicles through which Wall Street bets on the senior healthcare market.

This post appeared first on 24/7 Wall St.